Abdomen distended
|
phenotype |
Digestive System Diseases
|
Finding
|
103
|
6
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Acquired hypothyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
13
|
2
|
0.020 |
None |
1.000 |
2 |
1
|
1994 |
2005 |
Activating thyroid-stimulating hormone receptor defect
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Acute Promyelocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
651
|
21
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2018 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adenocarcinoma, Oxyphilic
|
disease |
Neoplasms
|
Neoplastic Process
|
135
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.400 |
None |
0.926 |
27 |
1
|
1993 |
2013 |
Adenoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
49
|
|
0.300 |
None |
1.000 |
1 |
|
1993 |
1993 |
Adenoma, Microcystic
|
disease |
Neoplasms
|
Neoplastic Process
|
45
|
|
0.300 |
None |
1.000 |
1 |
|
1993 |
1993 |
Adenoma, Monomorphic
|
disease |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.300 |
None |
1.000 |
1 |
|
1993 |
1993 |
Adenoma, Trabecular
|
disease |
Neoplasms
|
Neoplastic Process
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
1993 |
1993 |
Adenomatous goiter
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
23
|
4
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Adrenal Cancer
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
20
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Adrenal Gland Neoplasms
|
group |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
94
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Advanced bone age
|
phenotype |
|
Finding
|
64
|
4
|
0.100 |
None |
|
0 |
|
|
|
Agitation
|
phenotype |
Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
109
|
4
|
0.100 |
None |
|
0 |
|
|
|
Agitation, CTCAE 3.0
|
phenotype |
|
Finding
|
87
|
|
0.100 |
None |
|
0 |
|
|
|
Agitation, CTCAE 5.0
|
phenotype |
|
Finding
|
87
|
|
0.100 |
None |
|
0 |
|
|
|
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.040 |
None |
1.000 |
4 |
|
1991 |
2012 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.330 |
None |
1.000 |
4 |
|
1991 |
2008 |
Anaplastic thyroid carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
392
|
16
|
0.030 |
None |
1.000 |
3 |
|
1994 |
2000 |
Antiphospholipid Syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
99
|
17
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Ataxia Telangiectasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
384
|
698
|
0.030 |
None |
1.000 |
3 |
|
1999 |
2018 |